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Abstract
Objectives: The amount of tissue that is ablated or necrosed at the line of parenchymal transection is
of clinical significance in the interpretation of resection margin status following hepatic resection. The aim
of this study was to define the extent of parenchymal ablation and necrosis in liver tissue using the
Harmonic Scalpel™, the LigaSure™, the Cavitron Ultrasonic Surgical Aspirator® (CUSA®) and the
Aquamantys® dissector ex vivo.
Methods: Mounted blocks of non-perfused bovine liver were transected using the Harmonic Scalpel™,
LigaSure™, CUSA® and Aquamantys® devices. Outcome measures included parenchymal ablation
(ablation band widths and weights) and tissue necrosis band widths along the line of transection. Each
experiment was replicated five times.
Results: All devices were associated with parenchymal ablation (Harmonic Scalpel™, 4.73  1.62 mm;
LigaSure™, 4.55  2.02 mm; CUSA®, 7.16  2.87 mm; Aquamantys®, 4.75  1.43 mm) and tissue
necrosis (Harmonic Scalpel™, 1.07  0.46 mm; LigaSure™, 1.36  0.36 mm; CUSA®, 0.81  0.21 mm;
Aquamantys®, 0.81  0.36 mm).
Conclusions: The Harmonic Scalpel™, LigaSure™, CUSA® and Aquamantys® devices were associ-
ated with bands of tissue loss along the hepatic parenchymal transection line in this benchtop cadaveric
model. This should be taken into account in the interpretation of resection margin status following liver
resection.
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Introduction
Liver resection provides the only potential cure for patients with
colorectal liver metastases. Defining an adequate margin of resec-
tion (the distance from the tumour edge to the cut surface of the
liver) is contentious.1 Historically, an inability to achieve a 10-mm
margin of clearance was considered a contraindication to resec-
tion.2 Several studies now indicate that a resection margin of
< 10 mm should not preclude a patient from undergoing liver
resection, provided themargin itself is clear of tumour (i.e. there is
no tumourwithin 1 mmof the cut surface of the liver).3–9However,
interpreting these data is difficult because the evidence from pro-
spective trials is limited. In addition, the various studies have used
different parenchymal transection techniques and many of the
large-cohort studies span the pre- and post-chemotherapy eras.
The method of liver transection has a bearing on how margin
positivity is interpreted.3,5,9,10 A range of non-ablative (finger
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fracture, Kelly clamp/crush and vascular stapling devices) and
ablative techniques using the Harmonic Scalpel™ (Ethicon
Endo-Surgery, Inc., Johnson & JohnsonMedical Ltd,Wokingham,
UK), the LigaSure™ (Covidien Ltd, Fareham, UK), the Cavitron
Ultrasonic Surgical Aspirator® (Integra CUSA EXcel®; Integra
Neurosciences Ltd,Andover,UK) and the Aquamantys® (formerly
TissueLink™) (Medtronic Advanced Energy, Portsmouth, NH,
USA) devices are available for hepatic parenchymal transection.11
When an ablative transection technique is used, a band of tissue is
lost at the line of transection. If this is adjacent to the edge of the
tumour, it may lead to the false reporting of a positive margin. The
extent of tissue loss that occurs during liver transection with each
of the Harmonic Scalpel™, LigaSure™, CUSA® and Aquamantys®
devices has not previously been reported. The aim of this study
was to define the extent of parenchymal ablation and tissue necro-
sis achieved using each of these devices in a non-perfused bench-
top cadaveric model.
Materials and methods
The instruments were assembled according to the manufacturers’
instructions.A 15-mmHarmonic Scalpel ACE™was connected to
the Harmonic Generator 300™ (Ethicon Endo-Surgery, Inc.). The
5-mm LigaSure™ V Sealer/Divider was connected to the Force
EZ™ generator (Valleylab Inc., Boulder, CO, USA). The EXcel™ 8
Ultrasonic Surgical Aspirator System (Integra Neurosciences Ltd)
was connected to the 23-kHz CUSA® handpiece, and the Aqua-
mantys® Pump Generator was connected to the Aquamantys® 9.5
XL Bipolar Sealer (Medtronic Advanced Energy). All devices were
used at the manufacturers’ recommended settings for liver
transection. The Harmonic Scalpel™ was set at a minimum of 3
and a maximum of 5. The LigaSure™ was used at a maximum of
350 W. The CUSA® was used at 2* setting at 100% amplitude
(30 ms on/10 ms off), 60% suction (ª 400 mmHg) and 5 ml/min
irrigation. The Aquamantys® was used at 170 W at a medium flow
rate of 22 ml/min.
To measure liver tissue ablation and necrosis, blocks of homo-
geneous bovine liver measuring 5 ¥ 5 ¥ 1 cm, harvested from
freshly killed animals, were mounted on graded cork blocks
(Fig. 1). Pre-transection mounted and unmounted liver weights
were recorded. All tissue reached the ambient controlled tempera-
ture of the laboratory (20 °C) before transection commenced.
Liver tissue was transected through the centre of each block. Fol-
lowing transection, the distance between cut edges (ablation band
width) was measured using electronic Vernier 46610 callipers
(Draper Tools Ltd, Southampton,UK) at five points at 1-cm inter-
vals along the length of transection. Transection was repeated five
times by the same operator (JSH). Post-transection mounted and
unmounted liver weights were recorded. The tissue was fixed in
formalin, processed and stained with haematoxylin and eosin
(H&E). The band of necrosis adjacent to the resection margin
(necrosis band width) was measured by a blinded gastrointestinal
histopathologist (AMZ). Representative sections were imaged
using the Hamamatsu Digital Nanozoomer® (Hamamatsu
Photonics UK Ltd, Welwyn Garden City, UK).
Data were analysed using spss for Windows Version 14 (SPSS,
Inc., Chicago, IL, USA). Data are expressed as the
mean standard deviation. The statistical significance of differ-
ences among groups was assessed using Student’s t-test
(unpaired). Differences were considered statistically significant
at P < 0.05.
Results
Parenchymal ablation
Parenchymal ablation measurements were validated in a series of
pilot studies using the Harmonic Scalpel™. Both the CUSA® and
Aquamantys® devices required a second instrument to divide the
small vessels along the line of transection. Measurements were
made following the division of this band. Figure 2a summarizes
the ablation band widths achieved using the four devices.
Figure 2b shows the percentage weight loss following the transec-
tion of the blocks using the Harmonic Scalpel™ and the LigaS-
ure™ device. This was significantly greater for the LigaSure™ tool.
It was not possible to evaluate weight changes accurately following
transection with the CUSA® and Aquamantys® tools because
saline irrigation was required for these transections.
Tissue necrosis
Figure 3 shows tissue necrosis adjacent to the resection margin for
each of the four devices in H&E-stained sections of bovine liver.
Figure 2c summarizes the necrosis band widths obtained using
each of the four tools. Significantly greater necrosis band widths
were obtained using the LigaSure™ device.
Discussion
Resection margin status is an important prognostic factor follow-
ing liver resection for colorectal metastases and has implications
for the planning of future treatment.3,5,6,8,12 However, the accurate
interpretation of margin status is difficult as the use of ablative
Figure 1 Schematic demonstrating the benchtop cadaveric model
HPB 829
HPB 2012, 14, 828–832 © 2012 International Hepato-Pancreato-Biliary Association
transection techniques may encroach on the clear margin and lead
to the over-reporting of false positive margins.3,5,10 This study
demonstrated that the Harmonic Scalpel™, LigaSure™, CUSA®
and Aquamantys® devices were all associated with bands of tissue
ablation along and tissue necrosis on either side of the line of
transection.
Liver parenchyma is a highly vascular tissue containing hepa-
tocytes and non-parenchymal cells suspended in a collagen-based
extracellular matrix through which runs a network of vessels and
biliary structures. Successful liver transection requires the achieve-
ment of haemostasis and the sealing of ductal structures.11 The
Harmonic Scalpel™ uses ultrasound energy to cause coagulation
and protein (collagen) denaturation to dissect and seal tissue. The
tissue-cutting effect is achieved by the longitudinal vibration
effect. In experimental models, the Harmonic Scalpel™ has been
shown to seal vessels up to 3 mm in diameter.11 The LigaSure™
system uses a combination of radiofrequency energy and com-
pression to dissect tissue. The cutting effect is achieved with a
built-in blade. In experimental models, the LigaSure™ device has
proved able to seal vessels up to 7 mm in diameter.11 The CUSA®
dissector uses ultrasonic energy transmitted via saline released
from its tip to fragment parenchymal tissue that is then aspirated
to expose blood vessels and ductal structures that can be electro-
cauterized, ligated or clipped.11 The Aquamantys® dissector uses
radiofrequency energy conducted through saline released from its
tip. This coagulates tissue, sealing small vascular and biliary struc-
tures, and isolating larger structures that can be electrocauterized,
ligated or clipped.11
The ablative band widths for both the Harmonic Scalpel™ and
the LigaSure™ device correspond to the maximum diameters
of the instrument tips used in this study (Harmonic Scalpel™,
5.5 mm; LigaSure™, 5.0 mm). Other tip sizes are available. Bands
of necrotic tissue measuring 1.0–1.5 mm were found on either
side of the line of transection. There was a significant difference in
tissue weight loss following liver transection with the LigaSure™
tool compared with that performed using the Harmonic
Scalpel™. This corresponds with the larger surface area of the
tip of the LigaSure™ device.
The ablation/aspiration band width of the CUSA® is operator-
dependent. In this cadaveric model, an arc of 7 mm was sufficient
to expose small vessels and biliary structures. In an in vivo context,
in which there is concern about margin clearance, the operator
may widen this arc of aspiration to clear additional tissue at the
adjacent margin. Because the tissue is aspirated, it is usually not
possible to evaluate it formally.10
The Aquamantys® device produced a wide band of coagula-
tion adjacent to the line of transection, but this was not reflected
in either the ablative or necrotic band width. Although the device
led to disruption of the extracellular matrix within this coagu-
lative band to a distance of 2 mm from the resection margin,
there was no clear evidence of tissue necrosis beyond 1 mm. The
impact of this coagulation effect on tumour cell viability is not
known.
The selection of liver transection technique is dependent on the
surgeon’s experience and preference. Non-ablative techniques
remain the first choice at many centres and provide excellent
perioperative and longterm outcomes.13,14 The CUSA® is also
used widely and provides flexibility when margin clearance
is in question.10,11,15,16 The advantages of newer coagulative
devices (the Harmonic Scalpel™,17–20 the LigaSure™21–24 or the
Aquamantys®25–27) over existing transection techniques for
parenchymal disease have yet to be demonstrated in large clinical
trials. In laparoscopic liver resection, the Harmonic Scalpel™ and
the LigaSure™ tool enable precise dissection through small vas-
cular and biliary structures in which the use of CUSA® is less
practical. However, these devices may be used in combination
with other techniques to secure larger vessels.11,28
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Figure 2 (a) Widths of bands of tissue ablated with the various
devices. Comparisons between devices show: A vs. B, P = 0.868;
A vs. C, P = 0.139; A vs. D, P = 0.986; B vs. C, P = 0.117; B vs. D,
P = 0.832, and C vs. D, P = 0.128. (b) Percentage loss in tissue
weight after ablation. The difference between outcomes with
devices A and B is significant at P = 0.006. (c) Widths of tissue
necrosis adjacent to the ablation zone. Comparisons between
devices show: A vs. B, P = 0.047; A vs. C, P = 0.036; A vs. D,
P = 0.133; B vs. C, P = 0.003; B vs. D, P = 0.006, and C vs. D,
P = 0.897
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There are several limitations to this study. The work was
undertaken in a non-perfused benchtop cadaveric model. It
would be valuable to compare the different ablative techniques
in vivo in order to assess ablation and necrosis more accurately in
the presence of the heat sink effect that occurs in perfused liver
tissue. It would also be of value to assess the performance of
these devices in a model for metastatic disease and in cadaveric
human tissue to determine how the necrotic effect varies in
tumour cells and to establish how performance changes in the
presence of parenchymal disease (sinusoidal injury, steatohepati-
tis, fibrosis and cirrhosis).
In a quest to improve rates of resectability, a more aggressive
approach to resection has been advocated. This includes downsiz-
ing with chemotherapy29 and the adoption of a variety of
parenchyma-preserving strategies.30 The interpretation of margin
status in this setting is, therefore, crucial for the planning of
further treatment and for predicting prognosis. The findings of
the present study demonstrate that transection with the Har-
monic Scalpel™, LigaSure™, CUSA® and Aquamantys® devices is
associated with bands of parenchymal ablation and necrosis at the
resection margin. This must be considered when interpreting
resection margin status following liver resection for colorectal
liver metastases. Furthermore, when clearance of the resection
margin is in question, an ablative rather than a non-ablative
transection technique may be preferred in order to reduce the
incidence of recurrence at the resection margin.
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